Trial Profile
Prospective, single-institution, non-randomized study of aprepitant in patients with thoracic malignancies to treat chemotherapy induced nausea and vomiting (CINV)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs Aprepitant (Primary) ; Dexamethasone; Granisetron
- Indications Chemotherapy-induced nausea and vomiting
- Focus Therapeutic Use
- 12 Dec 2015 New trial record